These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 22454242

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis.
    Andreou D, Söderman E, Axelsson T, Sedvall GC, Terenius L, Agartz I, Jönsson EG.
    Psychiatry Res; 2015 Sep 30; 229(1-2):497-504. PubMed ID: 26142836
    [Abstract] [Full Text] [Related]

  • 3. Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers.
    Andreou D, Saetre P, Kähler AK, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG.
    Eur Neuropsychopharmacol; 2011 Sep 30; 21(9):700-4. PubMed ID: 21295953
    [Abstract] [Full Text] [Related]

  • 4. Tryptophan hydroxylase gene 1 (TPH1) variants associated with cerebrospinal fluid 5-hydroxyindole acetic acid and homovanillic acid concentrations in healthy volunteers.
    Andreou D, Saetre P, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG.
    Psychiatry Res; 2010 Dec 30; 180(2-3):63-7. PubMed ID: 20580984
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia.
    Shinkai T, De Luca V, Hwang R, Müller DJ, Lanktree M, Zai G, Shaikh S, Wong G, Sicard T, Potapova N, Trakalo J, King N, Matsumoto C, Hori H, Wong AH, Ohmori O, Macciardi F, Nakamura J, Kennedy JL.
    Neuromolecular Med; 2007 Dec 30; 9(2):169-77. PubMed ID: 17627036
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers.
    Jönsson EG, Bah J, Melke J, Abou Jamra R, Schumacher J, Westberg L, Ivo R, Cichon S, Propping P, Nöthen MM, Eriksson E, Sedvall GC.
    BMC Psychiatry; 2004 Mar 04; 4():4. PubMed ID: 15102340
    [Abstract] [Full Text] [Related]

  • 10. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers.
    Jönsson EG, Nöthen MM, Gustavsson JP, Neidt H, Bunzel R, Propping P, Sedvall GC.
    Psychiatry Res; 1998 Jun 02; 79(1):1-9. PubMed ID: 9676821
    [Abstract] [Full Text] [Related]

  • 11. Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample.
    Corvin A, McGhee KA, Murphy K, Donohoe G, Nangle JM, Schwaiger S, Kenny N, Clarke S, Meagher D, Quinn J, Scully P, Baldwin P, Browne D, Walsh C, Waddington JL, Morris DW, Gill M.
    Am J Med Genet B Neuropsychiatr Genet; 2007 Oct 05; 144B(7):949-53. PubMed ID: 17492767
    [Abstract] [Full Text] [Related]

  • 12. HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses.
    Lappalainen J, Long JC, Virkkunen M, Ozaki N, Goldman D, Linnoila M.
    Biol Psychiatry; 1999 Sep 15; 46(6):821-6. PubMed ID: 10494451
    [Abstract] [Full Text] [Related]

  • 13. A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index.
    Ducci F, Newman TK, Funt S, Brown GL, Virkkunen M, Goldman D.
    Mol Psychiatry; 2006 Sep 15; 11(9):858-66. PubMed ID: 16770335
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Brain-derived neurotrophic factor gene variation influences cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol concentrations in healthy volunteers.
    Jönsson EG, Saetre P, Edman-Ahlbom B, Sillén A, Gunnar A, Andreou D, Agartz I, Sedvall G, Hall H, Terenius L.
    J Neural Transm (Vienna); 2008 Dec 15; 115(12):1695-9. PubMed ID: 18781277
    [Abstract] [Full Text] [Related]

  • 16. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
    von Holst H, Lindquist C, Sedvall G.
    Acta Neurochir (Wien); 1985 Dec 15; 77(3-4):146-51. PubMed ID: 2416192
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of a novel mGlu₂/₃ receptor agonist prodrug, LY2140023 monohydrate, on central monoamine turnover as determined in human and rat cerebrospinal fluid.
    Lowe S, Dean R, Ackermann B, Jackson K, Natanegara F, Anderson S, Eckstein J, Yuen E, Ayan-Oshodi M, Ho M, McKinzie D, Perry K, Svensson K.
    Psychopharmacology (Berl); 2012 Feb 15; 219(4):959-70. PubMed ID: 21847569
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.